Syverson Strege & Co’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-870	Closed	-$69.2K	–	431
2023 Q1	$69.2K	Buy	+870	New	+$69.2K	0.03%	107
2021 Q4	–	Sell	-510	Closed	-$24K	–	428
2021 Q3	$24K	Buy	+510	New	+$24K	0.02%	179